Ocular

RSS

Tolmetin eyedrop formulation evaluated in rabbits

Sep. 9, 1997

Improved IOP-lowering prostaglandin analogues from Alcon

Sep. 4, 1997

Alcon reports new agents for controlling IOP

Aug. 26, 1997

CAT's anti-TGF-beta2 antibody approved for phase I/IIa trials

Aug. 26, 1997

FDA approves expansion of Sunrise Technologies' hyperopia study

Aug. 26, 1997

InSite Vision initiates phase II study of ISV-120

Aug. 21, 1997

Generic levobunolol approved in Canada

Aug. 13, 1997

FDA releases Staar's implantable contact lens for phase II trials

Aug. 11, 1997

Boston Life Sciences begins preclinical program for ophthalmic indications of antiangiogenic product

July 18, 1997

New insights into glaucoma and implications for drug therapy

July 15, 1997